HLF Herbalife Ltd.
Herbalife Ltd., together with its subsidiaries, provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers weight management products, including meal replacement, protein shakes, drink mixes, weight loss supplements, healthy snacks, and metabolism boosting teas; targeted nutrition products comprising functional beverages and dietary and nutritional supplements containing herbs, vitamins, minerals and other natural ingredients; energy, sports, and fitness products; and facial skin care, body care, and hair care products. The company also provides literature, promotional, and other materials, such as start-up kits, sales tools, and educational materials. It sells its products through sales representatives, independent service providers, and company-operated retail stores and platforms. The company was formerly known as Herbalife Nutrition Ltd. and changed its name to Herbalife Ltd. in April 2023. Herbalife Ltd. was founded in 1980 and is headquartered in Los Angeles, California.…
Industry Peers
Packaged FoodsKey Statistics
About Herbalife (NYSE: HLF)
›
Herbalife (NYSE: HLF) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Packaged Foods industry, part of the Consumer Defensive sector, and reports about 8,500 employees.
The shares were at 15.57 USD on 19 November 2026, up 68.7% over 52 weeks. Its 52-week range is 8.650 USD to 20.40 USD: the price is 23.7% below the high and 80.0% above the low.
At a market capitalisation of 1.63B USD, it trades at 9.2 times trailing earnings and 5.1 times forward earnings. The median trailing P/E of its 18 largest Packaged Foods peers is 24.8, a discount of 63% for HLF.
Herbalife reports return on equity of -44.3%, an operating margin of 9.8% and revenue up 6.0% year over year.
Its debt exceeds its cash by 1.70B USD. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 17.33 USD is 11.3% above the current price. The next earnings report is expected on 17 February 2027.